P-127  HIGH DOSE RATE VERSUS LOW DOSE RATE BRACHYTHERAPY IN TREATMENT OF CERVICAL CANCER

Ar Kar Sai¹, Boris Ivanovich Polikov²

¹Department of Obstetrics and Gynaecology, Defence Services Obstetrics and Gynaecology and Child Health Hospital, Myanmar, ²Academic Unit, Department of Oncology, Moscow Medical Academy, Russia

P-128  CONCURRENT CHEMORADIOTHERAPY COMPARED WITH RADIOTHERAPY ALONE IN INTERMEDIATE-RISK STAGE IB-IIA CERVICAL CANCER AFTER HYSTERECTOMY AND PELVIC LYMPHADENECTOMY

Chang Hoon Song¹, Hak Jae Kim¹, Hong-Gyun Wu¹, Jae Won Kim², Soon Beom Kang², Sung Whan Ha¹

¹Department of Radiation Oncology, Seoul National University College of Medicine, Korea, ²Department Obstetrics and Gynecology, Seoul National University College of Medicine, Korea

P-129  Established LMP2-Biomarker for Development of Diagnosis and Anti-tumor Drug against Uterine Leiomyosarcoma

Takuma Hayashi¹, Akiko Horiuchi², Kenji Sano³, Ikuo Konishi⁴

¹Department of Immunology and Infectious Disease, Shinshu University Graduate School of Medicine, Japan, ²Department of Obstetrics and Gynecology, Shinshu University School of Medicine, ³Department of Clinical Medicine, Shinshu University School of Medicine, ⁴Department of Obstetrics and Gynecology, Kyoto University School of Medicine

P-130  QUALITY OF LIFE IN CERVICAL CANCER

Sukumarn Sunersak Swangvaree, Tewinr Kosiyatakul

Gynecologic Oncology, National Cancer Institute, Thailand

P-131  The impact of lymph node ratio on tumor recurrence and survival after staging laparotomy for advanced epithelial ovarian cancer

Eun Ji Nam¹, San Hui Lee¹, Jiheum Paek¹, Yong Wook Jung¹, Sang Wun Kim¹, Jae Wook Kim², Sunghoon Kim¹, Young Tae Kim¹

¹Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Korea, ²Department of Gynecologic Oncology, Kwandong University College of Medicine

P-132  Identification of a functional role for TOM40 and NP in ovarian cancer

HanByoul Cho, Jaehoon Kim

Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Korea

P-133  Paraneoplastic Cerebellar Degeneration (PCD) in patients with Ovarian cancer, A review of 112 cases

Nishant Tageja¹, Jason Valent², Sachin Gupta²

¹Department of Internal Medicine, Wayne State University/Detroit Medical Center, USA, ²Division of Hematology/Oncology, Wayne State University/ Karmanos Cancer Institute

P-134  SEQUENTIAL SUNITINIB AND SORAFENIB IN METASTATIC RENAL CELL CARCINOMA

Yong Wha Moon, Min Hee Hong, Hyo Song Kim, Sang Joon Shin, Hei-Cheul Jeung, Joong Bae Ahn, Hyun Cheol Chung, Sun Young Rha

Yonsei University College of Medicine, Korea

P-135  NON-INVASIVE BLADDER CANCER RECURRENCE AFTER BLADDER CANCER RECURRENCE AFTER BLADDER-PRESERVING THERAPY FOR MUSCLE-INVASIVE BLADDER CANCER

Mizuki Onozawa, Naoto Miyanaga, Takehiro Oikawa, Jun Miyazaki, Noritoshi Sekido, Koji Kawai, Toru Shimazui, Hideyuki Akaza

Department of Urology, University of Tsukuba, Japan

P-136  Perineural invasion and grade of differentiation have prognostic significance in gall bladder cancer after surgery

Myung Ah Lee, Eun-Seon Chung, Jin-Hyoung Kang, Young-Seon Hong, Hoo Geun Chun

Department of Medical Oncology, Catholic University, Korea

P-137  EFFECTIVENESS AND USEFULNESS OF MASS SCREENING FOR PROSTATE CANCER IN JAPAN: THE EXPERIENCE OF A UNIVERSITY HOSPITAL

Yasuhide Kitagawa, Atsushi Mizokami, Mikio Namiki

Department of Integrative Cancer Therapy and Urology, Kanazawa University, Japan

P-138  Feasibility of MRS for the evaluation of recurrence after the focal therapy with HIFU in the treatment of prostate cancer

Satoru Muto¹, Tatsuro Kaminaga², Tomoka Kumamoto¹, Tatsuro Koseki¹, Takashi Yoshii¹, Koujiro Nishio¹, Keisuke Saito¹, Syuuji Isotani¹, Yutaka Kamiyama¹, Hisamitsu Ide¹, Shigeo Horie¹

¹Department of Urology, Teikyo University, Japan, ²Department of Radiology, Teikyo University, Japan

↑ Page Top